Indeed, stimulation of both TICs and LPMCs with IL-34 enhanced the expression of CD163 and CD206, typical markers of type 2 macrophages, a subset of cells that play critical roles in the promotion of tumor development, progression, metastasis, and therapeutic resistance18. The gene discussed is CD163; the disease is neoplasm.